9
Study Population
Administration
Characteristics Considerations
Patients aged 65+ with a
solid tumor malignancy
or lymphoma starting
a new chemotherapy
regimen (any-line)
PRO/Administered; 5 min
Available online at:
http://www.mycarg.
org/Chemo_Toxicity_
Calculator
Can ask GA variables as part
of history or include as part of
PRO assessment
Patients aged 70+ years
with histologically
proven cancer who were
starting chemotherapy
PRO/Administered;
Estimated time to
completion is on par with
full GA (20-30 minutes)
Available online:
https://moffitt.org/
for-healthcare-providers/
clinical-programs-and-
services/senior-adult-
oncolog y-program/
senior-adult-oncolog y-
program-tools
e CRASH Scale includes
GA measures known also
to predict other adverse
outcomes such as mortality,
functional decline, and
hospitalizations: IADLs,
MMSE, and MNA.
Study Population and
Evidence
Administration
characteristics Considerations
Several large studies have
been conducted that
include patients aged
70+, which included
patients with both
solid and hematologic
malignancies starting a
new chemotherapy agent.
G8 is independently
associated with mortality
(1 year and 3 years) even
when controlling for
ECOG PS and stage of
cancer.
Administered; 5-10 min G8 can also be used as a
screening tool to identify
older patients who need more
comprehensive GA.
